Companies / California / Evofem Biosciences

· rebuilt nightly from public records

Signal Sheet

Selling to Evofem Biosciences? Who to reach and why now

San Diego, California is home to Evofem Biosciences, a publicly listed pharmaceutical preparations company. It raised $925K in Jun 2025 and its filings name 6 officers. Everything below links to the record it came from.

Listed company · Pharmaceutical Preparations · California

The easy button for new customers

Lakewave's AI keeps accounts like this one coming. Your pipeline refills while you sleep.

Every night it scans funding, filings, new officers, hiring, contracts, permits and bids, finds the accounts that fit what you sell, and delivers each with outreach and a pursuit plan. Just need a list? Its AI waterfall builds one with verified, reachable contacts.

SourceNew accounts that match what you offer, added as the signals land. The list never runs dry.
Reach outA first email written from why the account is hot, then a drip sequence that follows up until they reply. Sent from your own mailbox, with every open and reply tracked.
PursueAn AI-written plan built from your value proposition and the customer's compelling event: who to call, what to lead with, and the next step to win it. In early access.
Start your free trial →Tell it what you sell and where. Your list stays yours.

Who to reach

The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names

RoleContactSourceWhy they matter now
Executive OfficerSaundra PelletierSEC filing, Jun 2025Named officer in the filing; part of the buying group
Executive OfficerIvy ZhangSEC filing, Jun 2025Named officer in the filing; part of the buying group
Chief Technology OfficerColin RutherfordSEC filing, Jun 2025Technology and tooling decisions
Chief Technology OfficerKim KamdarSEC filing, Jun 2025Technology and tooling decisions
Chief Technology OfficerLisa RarickSEC filing, Jun 2025Technology and tooling decisions
Chief Technology OfficerTony O'BrienSEC filing, Jun 2025Technology and tooling decisions
For sellersWhy Evofem Biosciences is worth a call this quarterBuy Window: open · major agreement Oct 2026
Oct 2026Oct 2026

Corporate event

Signed a material agreement

Corporate event
$925K

Raised

Equity raise reported to the SEC, Jun 2025. Money arrives before the spending plan does.

Capital
$1.7M2 months

Back-to-back raises

2 equity raises in 2 months. Repeat funding is a company buying for growth, not maintenance.

Pattern
Track Evofem Biosciences with a free trial →Get the next signal the day it is filed or posted.
Email me the next Evofem Biosciences signalOne email when it files, raises, hires or posts a role. Watch up to 3 companies free, no password.

Why now

The most recent events first, refreshed every night. Each links to the record it came from.

WhenWhat happenedKindSource
Oct 9, 2026Signed a material agreementCorporate eventSEC filing
Sep 17, 2026Signed a material agreementCorporate eventSEC filing
Jun 26, 2025Raised $925K in equity from 1 investorsCapitalSEC filing
Apr 8, 2025Raised $750K in equity from 1 investorsCapitalSEC filing

Email format

Evofem Biosciences uses [email protected]. For someone named Jane Doe that is [email protected]. Lakewave confirmed this pattern. A company pattern is the common shape, not a guarantee for any one person. Many companies run more than one format at once: founders, early hires, acquired teams and regional offices often differ. So Lakewave does not apply one pattern across a whole company. It verifies the address for each person on its own, and a free trial gives you the email that reaches each person above.
Get verified addresses, free →

Reach Evofem Biosciences with emails that land

Lakewave finds the right people at Evofem Biosciences, checks every address against the mail server before you see it, and drafts a first email for each, which you review and send from your own inbox.

Try it on Evofem Biosciences with a free trial →

About Evofem Biosciences

HeadquartersSan Diego, California, per the filing address
Industry groupPharmaceutical Preparations
OwnershipListed company
Raise history$750K (Apr 2025) · $925K (Jun 2025)
Lakewave Rising4 · 1 kinds of evidence · rank in California after sign-up

Similar companies

Private-sector companies in the same industry group and state, ranked by Rising score.

Mirum Pharmaceuticals · 35Neonc Technologies · 35Abvc Biopharma · 29Adial Pharmaceuticals · 28Maplight Therapeutics · 26Latigo Biotherapeutics · 19See all 6 with a free trial →

Questions people ask

Did Evofem Biosciences raise funding in 2025?

Yes. Evofem Biosciences reported a $925K equity raise to the SEC on Jun 26, 2025 with 1 investors.

Who runs Evofem Biosciences?

The company's SEC filing, Jun 2025 names Saundra Pelletier (Executive Officer) among its officers.

Where is Evofem Biosciences headquartered?

San Diego, California, per the address on its SEC filing.

What is Evofem Biosciences's email format?

Evofem Biosciences uses [email protected]. For someone named Jane Doe that is [email protected]. Lakewave confirmed this pattern.

Does everyone at Evofem Biosciences use the same email format?

Not always. Many companies run more than one format at once: founders, early hires, acquired teams and regional offices often differ. That is why Lakewave does not apply one pattern across a whole company. It verifies the address for each person on its own, so you are not relying on a guessed pattern.

Know who is buying before the first callStart your free trial →

Know who is buying before the first call

Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.

Start your free trial

Compiled from public records and refreshed nightly; last updated Nov 16, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.